Skip to main content
. Author manuscript; available in PMC: 2016 Jun 8.
Published in final edited form as: J Pediatr. 2016 Mar 23;173:188–195.e4. doi: 10.1016/j.jpeds.2016.02.049

Table II.

Characteristics of children hospitalized with CAP with and without neurologic disorders

Characteristics Group 1
Group 2
Group 3
P value
Any neurologic disorder (n = 280) No. (%) Non-neurologic underlying condition (n = 934) No. (%) No underlying condition (n = 1144) No. (%) Group 1 vs 2 Group 1 vs 3
Male       160 (57.1)       524 (56.1)         607 (53.1)    .76    .22
Race/ethnicity
 Non-Hispanic white       137 (48.9)       314 (33.6)         488 (42.7) <.01  .06
 Non-Hispanic black         66 (23.6)       420 (45.0)         295 (25.8) <.01    .45
 Hispanic         62 (22.1)       132 (14.1)         258 (22.6) <.01    .88
 Other        15 (5.4)       68 (7.3)        103 (9.0)    .26    .05
Age groups
 <2 y         79 (28.2)       389 (41.7)         587 (51.3) <.01 <.01
 2–4 y         72 (25.7)       246 (26.3)         277 (24.2)    .84    .60
 5–17 y       129 (46.1)       299 (32.0)         280 (24.5) <.01 <.01
Insurance status
 Public       177 (63.2)       637 (68.2)         654 (57.2)    .12    .07
Parent’s education
 Some college or more       179 (63.9)       557 (59.6)         676 (59.1)    .20    .14
Non-neurologic underlying condition
 Any non-neurologic underlying condition       146 (52.1)       934 (100) NA <.01 NA
 Congenital heart disease         85 (30.4)         87 (9.3) NA <.01 NA
 Asthma/RAD         83 (29.6)         696 (74.5) NA <.01 NA
 Chronic lung disease         35 (12.5)         59 (6.3) NA <.01 NA
 Preterm birth (<37 wk)     26/79 (32.9) 192/389 (49.4) NA <.01 NA
 Immunosuppressive condition         12 (4.3)         27 (2.9) NA    .25 NA
 Other conditions*         14 (5.0)         43 (4.6) NA    .78 NA
Vaccination receipt status
H influenzae type B vaccine 183/213 (85.9) 543/631 (86.1)   534/625 (85.4)    .96    .86
 Pneumococcal vaccine 142/167 (85.0) 487/577 (84.4)   462/577 (80.1)    .72    .71
 Influenza vaccine 111/266 (41.7) 230/844 (27.3)   271/943 (28.7) <.01 <.01
Social factors
 Lives in household with smoker 81/278 (29.1) 361/929 (38.9) 388/1137 (34.1) <.01    .11
 Daycare attendance 41/202 (20.3) 253/757 (33.4)   287/961 (29.9) <.01 <.01
Reported symptoms
 Cough       255 (91.1)       898 (96.2)       1077 (94.1) <.01    .06
 Fever       251 (89.6)       851 (91.1)       1053 (92.1)    .46    .19
 Shortness of breath       197 (70.4)       710 (76.0)         750 (65.6)    .06    .13
 Vomiting/nausea       114 (40.7)       518 (55.5)         651 (56.9) <.01 <.01
 Diarrhea         64 (22.9)       253 (27.1)         401 (35.1)    .16 <.01
 Seizures         47 (16.8)         10 (1.1)          19 (1.7) <.01 <.01
Clinical findings
 Chest indrawing 149/276 (54.0) 542/925 (58.6) 587/1135 (51.7)    .17    .50
 Tachypnea 144/270 (53.3) 546/875 (62.4) 569/1083 (52.5)    .01    .82
 Hypoxia§ 138/278 (49.6) 334/926 (36.1) 424/1136 (37.3) <.01 <.01
 Altered mental status   26/266 (9.8)   22/924 (2.4)  10/1129 (0.9) <.01 <.01
 Hypotension     9/280 (3.2)     8/931 (0.9)     9/1133 (0.8) <.01 <.01
 Illness onset to hospital admission, d (median, IQR)             3 (1–6)             3 (1–5)               4 (2–6)    .58 <.01

NA, not applicable.

*

Other condition includes chronic kidney disease, diabetes mellitus, chronic liver disease, and history of splenectomy.

Based on verified vaccine information. For all 3 vaccines, vaccination is considered received if given ≥2 wk prior to admission. For H influenzae type B vaccine, this was based on 1459/1469 (99%) children ≥19 mo for whom information was available; vaccinated was defined as having received ≥3 doses H influenzae type B vaccine. For pneumococcal conjugate vaccine, this was based on 1272/1280 (99%) of children 19 mo to 12 y for whom information was available; vaccinated was defined as having received ≥3 pneumococcal vaccine doses. For influenza vaccine, this was based on 2053/2084 (99%) children ≥6 mo for whom information was available; vaccinated was defined as having received ≥1 influenza vaccine dose during season. An influenza season was defined as September 1 to August 31 of the concurrent year.

Tachypnea is defined as ≥60 breaths per min in infants <2 mo; ≥50 breaths per min in infants ≥2 mo to <12 mo; ≥40 breaths per min in children ≥1 y to <5 y; and ≥25 breaths per min in ≥5 y to <18 y.

§

Hypoxia is defined as an oxygen saturation <92% on presentation or the receipt of any supplemental oxygen on presentation.

Hypotension is defined as a systolic blood pressure <60 mm Hg in infants <1 mo; <70 mm Hg in infants ≥1 mo to <1 y; <70 mm Hg + (2 mm Hg * age in y) in children ≥1 y to <10 y; and <90 in children ≥10 y.